A quick spit test is as good as blood for detecting HIV, and could encourage self-testing initiatives in the US and Africa.
A quick spit test is as good as blood for detecting HIV, and could encourage self-testing initiatives in the US and Africa.
Should research that makes pathogens more deadly or infectious—or other dangerous research—be conducted in the first place?
Science taps a clinical trial that showed the benefits of antiretroviral treatment in HIV patients as 2011's breakthrough of the year.
Researchers identify a protein in semen that enhances the transmission of HIV in culture, but whether it increases infectivity in humans is not yet known.
The Medicines and Healthcare products Regulatory Agency (MHRA) warns against home testing kits for HIV and other sexually transmitted diseases.
Dwindling stocks in more than a dozen cancer drugs are delaying clinical trials.
In an essay entitled "Molecular Cut and Paste: The New Generation of Biological Tools," virologist William McEwan envisions a future where viruses are reprogrammed to become the workhorses of science and medicine.
The promise of viruses as biotech tools will help molecular biology fulfill its true potential.
A selection of quotes from past issues of The Scientist